Childhood leukaemia: transferring records to a paediatric haematologist

A childhood leukaemia second opinion needs a paediatric specialist and an accurate account of the child’s current programme. Sending a large folder without explaining the treatment phase can make the review slower. The goal is to preserve the diagnostic detail, the protocol already being followed and the clinical decisions that must not be delayed.

State the question and the child’s current care

Ask the treating paediatric haematologist to write a short referral. It should identify the diagnosis, current condition, treatment phase and reason for the review. Clarify whether the question is confirmation of the initial plan, interpretation of response or assessment after a relapse. An urgent care need should be communicated directly between teams.

The NCI’s childhood ALL information describes treatment designed for children and adolescents with age-specific considerations. Adult leukaemia information should not be used to change a child’s programme. Keep the exact protocol name and the risk-group wording assigned by the treating specialist; do not recalculate risk from an online article.

Make the protocol history easy to follow

• Include the original marrow, flow-cytometry and relevant molecular or chromosome reports.
• Identify the programme name, start date, current phase and completed treatment blocks.
• Attach the response assessments with their dates and test methods where reported.
• Record interruptions, severe reactions, infections and important admissions.
• Provide the current prescription list and contact details for the treating department.

If medicines were prescribed but not administered, mark that distinction. A planned schedule is not the same as an administration record. Ask the home team which summary best shows what the child actually received.

Arrange child-appropriate communication

Confirm that the receiving service accepts children of this age and has the relevant paediatric expertise. Ask who will explain the consultation to the child in an age-appropriate way and whether an interpreter is needed for the parents. Identify the parent or legal representative who will receive documents and discuss consent requirements with the hospital.

Send health records only through the agreed clinical channel. Avoid placing a child’s identifiable reports in public messages, review sites or social media while looking for advice.

Do not let travel interrupt the programme

Before a visit to Turkey, ask the treating team whether travel is appropriate and what care is needed during the interval. The receiving hospital should confirm the purpose of the visit, the responsible paediatric team and any admission arrangements. A hotel booking is not a medical handover.

Separate assessment costs from proposed treatment blocks and longer follow-up. Confirm accommodation arrangements for the accompanying adult and how records will return to the home team. If a specialised therapy is discussed, its relevance and actual availability must be confirmed by the treating hospital.

Report fever or deterioration according to the child’s urgent-care instructions rather than waiting for the international review. The useful result is a clear paediatric recommendation that can be shared between clinicians while necessary care continues.

A practical next step

For the practical arrangements, see An oncology second opinion: when it helps and how to prepare.

Sources

• NCI: Childhood Acute Lymphoblastic Leukemia Treatment